Pridopidine is a highly potent and highly selective S1R agonist in clinical development for neurodegenerative diseases including Huntington disease (HD, NCT04556656) and amyotrophic lateral sclerosis (ALS, NCT04615923). This evidence concerns the gene TMBIM4 and neurodegenerative disease.